About PreciseDx
PreciseDx is a private company based in New York, New York. It has reported $35,650,750 raised in three offerings on Form D since April 2024. Its chief executive is Eric Converse.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Oct 7, 2026 | $3,699,998fully sold | 9 | $411K | EquityRule 506(b) | Form D ↗ |
| May 28, 2025 | Jun 6, 2025 | $11,230,074of $15.0M target | 9 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Feb 20, 2024 | Apr 1, 2024amended Apr 3, 2024 | $20,720,678of $28.2M target | 10 | $2.0M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, three offerings | $35,650,750 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on PreciseDx's Form D filed Oct 7, 2026.
Paul Roma
Chairman
Also a founder, chairman of the board at Quiver Bioscience and a chief executive officer and director at Rialtic.
WD
EL
Erik Lium
Director
MJ
Michael Hennessy Jr.
Director
ES
Earlier filings also listed Wayne Brinster (chief executive officer and director, last listed Apr 2024).